Analyst picks & changes

BioChem Pharma Inc.

SoundView Financial analyst Reijer Lenstra initiated coverage of BioChem Pharma Inc. with a "buy" and a one year price target of $16. Stock of the Canadian company is underfollowed,

Read the full 318 word article

How to gain access

Continue reading with a
two-week free trial.